BHVN - Biohaven Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$20.00
DETAILS
HIGH:
$30.00
LOW:
$11.00
MEDIAN:
$19.00
CONSENSUS:
$20.00
UPSIDE:
75.13%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-15 | Gentile Kimberly | officer: SVP, Clinical Operations | A-Award | 1,000 | $12.34 | $12K |
| 2026-08-06 | Yetimoglu John | director | ? | -- | -- | -- |
| 2026-07-09 | Volles Warren Karl | officer: Chief Legal Officer | ? | -- | -- | -- |
| 2026-07-09 | Volles Warren Karl | officer: Chief Legal Officer | ? | 95,250 | $41.93 | $4.0M |
| 2026-07-09 | Volles Warren Karl | officer: Chief Legal Officer | ? | 83,000 | $38.64 | $3.2M |
| 2026-07-09 | Volles Warren Karl | officer: Chief Legal Officer | ? | 175,000 | $11.52 | $2.0M |
| 2026-07-09 | Volles Warren Karl | officer: Chief Legal Officer | ? | 14,000 | -- | -- |
| 2026-07-09 | Volles Warren Karl | officer: Chief Legal Officer | ? | 300,000 | $7.00 | $2.1M |
| 2026-07-09 | Volles Warren Karl | officer: Chief Legal Officer | ? | 78,750 | $29.49 | $2.3M |
| 2026-04-28 | Mehta Kishan | director | A-Award | 68,693 | $9.61 | $660K |
| 2026-04-28 | Bailey Gregory | director | A-Award | 68,693 | $9.61 | $660K |
| 2026-04-28 | Heffernan Michael Thomas | director | A-Award | 68,693 | $9.61 | $660K |
| 2026-04-28 | Antonijevic Irina | director | A-Award | 68,693 | $9.61 | $660K |
| 2026-04-28 | CHILDS JOHN W | director | A-Award | 68,693 | $9.61 | $660K |
| 2026-04-28 | HUGIN ROBERT J | director | A-Award | 68,693 | $9.61 | $660K |
| 2026-04-28 | GREGORY JULIA P | director | A-Award | 68,693 | $9.61 | $660K |
| 2026-03-17 | Mehta Kishan | director | G-Gift | 17,342 | -- | -- |
| 2025-03-04 | CHILDS JOHN W | director | BUY | 28,400 | $30.43 | $864K |
| 2026-02-27 | Car Bruce | officer: Chief Scientific Officer | A-Award | 175,000 | $11.52 | $2.0M |
| 2026-02-27 | Coric Vlad | director, officer: Chief Executive Officer | A-Award | 550,000 | $11.52 | $6.3M |
| 2026-02-27 | Buten Matthew | officer: Chief Financial Officer | A-Award | 175,000 | $11.52 | $2.0M |
| 2026-02-27 | Gentile Kimberly | officer: SVP, Clinical Operations | A-Award | 175,000 | $11.52 | $2.0M |
| 2026-02-27 | Clark George C. | officer: VP, Chief Accounting Officer | A-Award | 50,000 | $11.52 | $576K |
| 2026-01-05 | Gentile Kimberly | officer: SVP, Clinical Operations | F-InKind | 1,956 | $9.93 | $19K |
| 2026-01-05 | Gentile Kimberly | officer: SVP, Clinical Operations | M-Exempt | 3,750 | -- | -- |